---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-061184"
form_type: "8-K"
ticker: "QNRX"
cik: "0001671502"
company_name: "Quoin Pharmaceuticals, Ltd."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:31:31.978667+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Quoin Pharmaceuticals sets 2025 AGM for August 21; shareholder proposal deadline June 30

## Summary
- 2025 Annual General Meeting scheduled for August 21, 2025.
- Shareholder proposals under Rule 14a-8 must be received by June 30, 2025.
- Notice for proxy solicitations for director nominees other than company's must be given by June 30, 2025.

## SEC filing metadata
- accession: 0001104659-25-061184
- form_type: 8-K
- ticker: QNRX
- cik: 0001671502
- company_name: Quoin Pharmaceuticals, Ltd.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/0001104659-25-061184-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1671502/000110465925061184/tm2518339d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-061184
- JSON: https://secwatch.observer/filing/0001104659-25-061184.json
- Plain text: https://secwatch.observer/filing/0001104659-25-061184.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.